Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral
intravenous |
| gptkbp:alsoKnownAs |
gptkb:gaboxadol
|
| gptkbp:CASNumber |
60643-86-9
|
| gptkbp:category |
investigational drug
GABAergic drug |
| gptkbp:chemicalFormula |
C6H9NO2
|
| gptkbp:clinicalTrialPhase |
discontinued
|
| gptkbp:developedBy |
gptkb:Lundbeck
|
| https://www.w3.org/2000/01/rdf-schema#label |
THIP
|
| gptkbp:IUPACName |
gptkb:4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol
|
| gptkbp:legalStatus |
not approved in US
|
| gptkbp:mechanismOfAction |
GABAA receptor agonist
|
| gptkbp:sideEffect |
dizziness
headache drowsiness |
| gptkbp:usedAs |
sedative
hypnotic |
| gptkbp:bfsParent |
gptkb:GABA_A_receptor
|
| gptkbp:bfsLayer |
6
|